Stryker reported 4Q21 orthopedic sales of $2.4 billion, +13.8% vs. 4Q20. For the full year of 2021, the company's orthopedic sales totaled $8.9 billion, +24.7% vs. 2020. We estimate Stryker's organic growth vs. 2019 was in the low single digits. The company's Mako robotic system remains a powerful growth driver as it approaches an install […]
Private investor clients of Connection Capital, the specialist private client investment business, have invested £6.7 million (~USD $9.4 million) in MatOrtho, to support its international growth and product development....
Historically, total ankle replacements have had low success rates compared to the more popular knee, hip and shoulder replacements. To put this into context, knee replacements have a success rate of nearly 96%, while ankle replacements succeed only 78% of the time, according to the American Academy of Orthopedic Surgeons. Patients opt for ankle fusion […]
Episurf Medical received an additional patent in China relative to the Episealer® Femoral Twin joint implant design process and expects to obtain CE Mark Approval for the Episealer Talus ankle implant.
The world of foot and ankle is vibrant and full of opportunity to solve real problems. Honesty in implant improvement must take place at the design stage. Foot and ankle has the trifecta of implants. Depending on the case, I need hardware, soft tissue reconstruction and a biologic enhancer. This is unique in orthopaedics, and the company that wins recognizes the problem to be solved in its totality and not just a piecemeal approach.
The 1H18 performance of companies that make up ~80% of the joint reconstruction market achieved 4.1% growth vs. 1H17. These companies posted 2.4% growth in 1H17 vs. 1H16. Here is a look at past activity and future predictions for hip, knee and extremities.